Menu
ncarol.com
  • Home
  • Music
  • Asheville Music
  • Books
  • Manufacturing
  • Health
  • Technology
  • Book Release
  • Financial
ncarol.com

Certified Nutraceuticals Partners with Colorado Researchers for Groundbreaking Study on KollaJell™ and Brain Health
ncarol.com/10282619

Trending...
  • Santa Your Way Announces Official 2026 Q4 Holiday Tour: Booking Open For Santa, The 5-star Grinch, And Dual Character Experiences Nationwide
  • Gabby Press Earns High Praise From Feathered Quill About the Unregulated Dangers of Second Generation Corporate AI
  • Warrant Activity, AVERSA™ Progress and a Potentially Transformative Fall Take Center Stage: Nutriband Inc. (N A S D A Q: NTRB)
Certified Nutraceuticals, Inc.
The study aims to validate KollaJell™ as the first and only collagen-based brain health product backed by clinical trials.

TEMECULA, Calif. - ncarol.com -- Temecula, CA—Certified Nutraceuticals Inc. announced the start of a clinical study on the cognitive benefits of KollaJell™, a patented jellyfish collagen supplement uniquely formulated to support brain health. The study aims to validate KollaJell™ as the first and only collagen-based brain health product backed by clinical trials.

The innovative study will utilize advanced brain imaging technologies, including electroencephalographic (EEG) scans, to measure cognitive function and brain activity before and after KollaJell™ supplementation. The project also utilizes computerized cognitive assessments to evaluate critical mental performance domains such as memory and multitasking. Results of this unique investigation are anticipated by April 2025 and will be published in peer-reviewed scientific journals.

The research team consists of Dr. G.M. Haase, who has developed numerous innovations in nutritional science, holds 12 U.S. patents, and has published 200 research papers. Neil Wolkodoff, Ph.D., is the Medical Program Director of the Colorado Center for Health and Sport Science and is an expert in health and performance metrics.

More on ncarol.com
  • Sawgrass Ford President Attributes Dealerships Success to Long-Term Employees
  • Ragin' Cajun Announces New Cheeseburger Seasoning on National Cheeseburger Day
  • Warrant Activity, AVERSA™ Progress and a Potentially Transformative Fall Take Center Stage: Nutriband Inc. (N A S D A Q: NTRB)
  • Santa Your Way Announces Official 2026 Q4 Holiday Tour: Booking Open For Santa, The 5-star Grinch, And Dual Character Experiences Nationwide
  • Put Your Herd on Your Phone: Kiko Nation Makes Livestock Management Simple

Abdul Alkayali, Senior Vice President of Certified Nutraceuticals noted, "CN has been at the forefront of nutritional innovation, with KollaJell™ standing as a testament to our commitment to science-backed health solutions. This clinical study represents a significant step toward establishing KollaJell™ as the only brain health supplement with academic-led clinical validation. The study will solidify the product's credibility and enhance our global market presence."

About Certified Nutraceuticals

Certified Nutraceuticals develops natural, functional, ingredient-based compounds that promote healthy and active lifestyles. Products are rooted in traditional medicine and validated by modern science and impact anti-aging on a cellular level, joint, brain, cardiovascular, and immune health.

Learn more at www.certifiednutra.com

Media Contact: Sara Alkayali, 951-600-3899.  Email: salkayali@certifiednutra.com

Media Contact
Abdul Alkayali
asalkayali@certifiednutra.com
951-600-3899


Source: Certified Nutraceuticals
Filed Under: Health

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • She Writes Python and Produces Music. KayeDinero Has a Question About AI Artists
  • Infinity Infusion Solutions Named Finalist for D Magazine's D CEO 2026 Excellence in Healthcare Awards
  • There and Back comes to Hillsborough
  • One Mile North of 8 Mile: KayeDinero Connects Detroit and Asheville on "Nine Mile"
  • Gabby Press Earns High Praise From Feathered Quill About the Unregulated Dangers of Second Generation Corporate AI
  • Canadian Tint Expo 2027: Why Every Window Tinter Should Compete in Niagara Falls on April 3rd & 4th
  • Detroit Roots, Film Scores and Python Shape KayeDinero's Asheville Sound
  • Building a Diversified Healthcare Platform as Exosome Science, Telehealth, Diagnostics & Strategic Acquisitions Converge: NexTel Medical (OTCID: MAJI)
  • Most Indiana Plane Crashes Happen Away from the State's Major Airports
  • L2 Aviation Welcomes Jason Marshall as Vice President of Sales and Business Development
  • Mom Era, Still That Girl: Family Art Tees 25% Off
  • Fashion vs. Fascism - Because Democracy Should Always Be In Style
  • From Degrassi to Cass Tech: The Unexpected Influences Behind Asheville's KayeDinero
  • Lee Gunn IV Shares Lessons From 40 Years in the Courtroom on PodNumbra Podcast
  • KayeDinero Takes "Appalachia" Above the Blue Ridge With New Aerial Music Visual
  • Michael H. Kaplan Recognized for 17 Years on PHPA Workers' Compensation Panel and Advocacy for Professional Athletes
  • International Society of Medical AI Convenes Global Faculty in Florence for ISMAI 2026
  • Boston Industrial Solutions Introduces Personalized Printing Training
  • Century Fasteners de Mexico Exhibiting at the 2026 Automotive & Aerospace Nearshoring Summit
  • Retell AI White Label Platform for Agencies Launched by VoiceAIWrapper, With Branded Client Portals and No Per-Minute Markup
_catLbl0 _catLbl1

Popular on ncarol.com

  • Parksy (parksy.com) Tackles the Most Common Parking Problem Nobody Talks About: Finding the Car Again - 165
  • Mito Health Passes One Million Lab Tests, Expands to Seven Categories of Preventive Health Testing - 164
  • Free JavaScript Charting Library ProEssentialsJS Permits Commercial Use. Highcharts, SciChart and LightningChart Free Tiers Do Not - 147
  • Robert DeMaio, Phinge CEO to Speak at 30th IIPLA 2026 on Securing IP, User Data & Digital Sovereignty via Verified App-less Tech. Attend the Live Q&A! - 130
  • From Temecula Wine Country to Canyon Lake: Parkway Construction Transforms Outdoor Spaces for Inland Homeowners - 129
  • Project CIVICA Report Finds 10,680 Non-Citizen Indicators on New York Voter Rolls — Including 88 Records with Recent Voting History - 126
  • Bspin Launches Lightning-Fast Crypto Gaming Expansion With Sportsbook, Poker, VIP Rewards, and Bitcoin Lightning Network Integration - 125
  • Patented Foodservice Products Company with Strong Gross Margins and Substantial Two-Year Revenue Growth Hits Market for $1.6 Million - 120
  • Gigasoft 2026 JavaScript Chart Comparison: ProEssentials, Highcharts, SciChart, LightningChart, ECharts - 118
  • Steve Thompson Launches StickyHealth to Tackle the Retention Gap in the Growing GLP 1 Market - 114

Similar on ncarol.com

  • Warrant Activity, AVERSA™ Progress and a Potentially Transformative Fall Take Center Stage: Nutriband Inc. (N A S D A Q: NTRB)
  • Infinity Infusion Solutions Named Finalist for D Magazine's D CEO 2026 Excellence in Healthcare Awards
  • Building a Diversified Healthcare Platform as Exosome Science, Telehealth, Diagnostics & Strategic Acquisitions Converge: NexTel Medical (OTCID: MAJI)
  • International Society of Medical AI Convenes Global Faculty in Florence for ISMAI 2026
  • Lawsuit Alleges American Deli Food Caused Severe Illness, Acute Kidney Failure, And Eight-day Hospitalization
  • European Patent for ALS Program Expands the Story: HOPE Deploys Robotic TMS & FDA Commercialization Path Advances: NRx Pharmaceuticals: NAS DAQ: NRXP
  • White Coat Financial Partners Announces Launch of Next Generation Practice Optimization Software
  • FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
  • Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
  • Piedmont Crossing Celebrates 40 Years of Caring, Community, and Connection
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute